- Home
- AXGN vs PSTX Comparison
AXGN vs PSTX Comparison
Compare AXGN & PSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXGN
- PSTX
- Stock Information
- Founded
- AXGN N/A
- PSTX 2014
- Country
- AXGN United States
- PSTX United States
- Employees
- AXGN N/A
- PSTX N/A
- Industry
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PSTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AXGN Health Care
- PSTX Health Care
- Exchange
- AXGN Nasdaq
- PSTX Nasdaq
- Market Cap
- AXGN 584.7M
- PSTX 249.1M
- IPO Year
- AXGN N/A
- PSTX 2020
- Fundamental
- Price
- AXGN $13.15
- PSTX $2.50
- Analyst Decision
- AXGN Strong Buy
- PSTX Strong Buy
- Analyst Count
- AXGN 4
- PSTX 2
- Target Price
- AXGN $15.00
- PSTX $15.00
- AVG Volume (30 Days)
- AXGN 370.0K
- PSTX 533.7K
- Earning Date
- AXGN 11-05-2024
- PSTX 11-07-2024
- Dividend Yield
- AXGN N/A
- PSTX N/A
- EPS Growth
- AXGN N/A
- PSTX N/A
- EPS
- AXGN N/A
- PSTX N/A
- Revenue
- AXGN $173,482,000.00
- PSTX $88,462,000.00
- Revenue This Year
- AXGN $18.49
- PSTX $36.53
- Revenue Next Year
- AXGN $12.78
- PSTX N/A
- P/E Ratio
- AXGN N/A
- PSTX N/A
- Revenue Growth
- AXGN 17.26
- PSTX N/A
- 52 Week Low
- AXGN $3.45
- PSTX $1.83
- 52 Week High
- AXGN $15.23
- PSTX $4.27
- Technical
- Relative Strength Index (RSI)
- AXGN 44.12
- PSTX 38.80
- Support Level
- AXGN $13.08
- PSTX $2.41
- Resistance Level
- AXGN $15.23
- PSTX $2.61
- Average True Range (ATR)
- AXGN 0.65
- PSTX 0.12
- MACD
- AXGN -0.17
- PSTX -0.01
- Stochastic Oscillator
- AXGN 12.97
- PSTX 24.66
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
About PSTX Poseida Therapeutics Inc.
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.